Mississippi's Point out Board of Health-related Licensure now prohibits prescribing, dispensing, or administrating compounded semaglutide for weight reduction, citing safety issues, but legislation differ from point out to condition. Prospects can seek advice from the FDA's BeSafeRx marketing campaign to navigate acquiring drugs safely and securely